BJHS Themes
The globalization of sera evaluation between 1895 and 1925
By Axel C. Huentelmann.
Abstract
Abstract During the development of an anti-diphtheria serum in the 1890s in France and Germany, the problem arose of how to evaluate the potency of an unstable substance of biological origin. This was solved by developing a complex, relational procedure, centred around standard toxin and sera, with guinea pigs and mice as bioindicators. After the marketing of anti-diphtheria serum in the German Empire in 1894, its production and sale were regulated by the state. The Royal Prussian Institute for Serum Research and Serum Survey soon became the global authority for the control and evaluation of biologicals; that is, substances of organic origin. This study analyses how serum evaluation transformed an unstable biological into an ‘objective’ remedy with a calculable therapeutic efficacy as measured in rodents.
Keywords
- Historical Medical Research and Treatments
- Globalization
- Potency
- German
- Empire
- Production (economics)
- Open access
Source
Published in BJHS Themes. The abstract is shown as published and remains the work of its authors; read the full article at the source.
Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.
